My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Growth factors in proliferative vitreoretinopathy.

    Charteris DG.

    Br J Ophthalmol. 1998 Feb;82(2):106. No abstract available. PMID: 9613372 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.

    Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M.

    Am J Ophthalmol. 2002 Jun;133(6):851-2.PMID: 12036691 [PubMed - indexed for MEDLINE]Related articles

    3.

    Subretinal "napkin-ring" membrane in proliferative vitreoretinopathy.

    Tabandeh H, Callejo SA, Rosa RH Jr, Flynn HW Jr.

    Arch Ophthalmol. 2000 Sep;118(9):1287-9.PMID: 10980777 [PubMed - indexed for MEDLINE]Related articles

    4.

    Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.

    Scott IU, Flynn HW Jr, Murray TG, Feuer WJ; Perfluoron study group.

    Am J Ophthalmol. 2003 Sep;136(3):454-63.PMID: 12967798 [PubMed - indexed for MEDLINE]Related articles

    5.

    Proliferative vitreoretinopathy.

    Tennant MT, Nelson ML, Blade KA, Garg SJ, Lane RG.

    Ophthalmology. 2007 Sep;114(9):1793-4; author reply 1794-5. No abstract available. PMID: 17822991 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.

    Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J.

    Am J Ophthalmol. 2000 May;129(5):678-80.PMID: 10844070 [PubMed - indexed for MEDLINE]Related articles

    7.

    Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.

    Troger J, Kremser B, Irschick E, Göttinger W, Kieselbach G.

    Graefes Arch Clin Exp Ophthalmol. 1998 Dec;236(12):900-3.PMID: 9865620 [PubMed - indexed for MEDLINE]Related articles

    8.

    Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis.

    Mondal S, Hussain N, Natarajan S.

    Am J Ophthalmol. 2008 Jul;146(1):145; author reply 145. No abstract available. PMID: 18573359 [PubMed - indexed for MEDLINE]Related articles

    9.

    Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.

    La Heij EC, van de Waarenburg MP, Blaauwgeers HG, Kessels AG, Liem AT, Theunissen C, Steinbusch H, Hendrikse F.

    Am J Ophthalmol. 2002 Sep;134(3):367-75.PMID: 12208248 [PubMed - indexed for MEDLINE]Related articles

    10.

    Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.

    Kon CH, Occleston NL, Aylward GW, Khaw PT.

    Invest Ophthalmol Vis Sci. 1999 Mar;40(3):705-12.PMID: 10067974 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Gelatinase B in proliferative vitreoretinal disorders.

    Abu El-Asrar AM, Dralands L, Veckeneer M, Geboes K, Missotten L, Van Aelst I, Opdenakker G.

    Am J Ophthalmol. 1998 Jun;125(6):844-51.PMID: 9645722 [PubMed - indexed for MEDLINE]Related articles

    12.

    Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.

    Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J.

    Am J Ophthalmol. 1999 Dec;128(6):763-5.PMID: 10612518 [PubMed - indexed for MEDLINE]Related articles

    13.

    Future perspectives in primary retinal detachment repair.

    Scott JD.

    Eye (Lond). 2002 Jul;16(4):349-52. No abstract available. PMID: 12101439 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Controversies in proliferative vitreoretinopathy tamponade and pharmacologic adjuvants.

    Young TA, D'Amico DJ.

    Int Ophthalmol Clin. 2005 Fall;45(4):163-71. Review. No abstract available. PMID: 16199975 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Vitrectomy for the treatment of retinal detachment uncomplicated by advanced proliferative vistreoretinopathy]

    Li C, Gu D.

    Yan Ke Xue Bao. 1998 Jun;14(2):97-9. Chinese. PMID: 12580042 [PubMed - indexed for MEDLINE]Related articles

    16.

    Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.

    Zhang X, Barile G, Chang S, Hays A, Pachydaki S, Schiff W, Sparrow J.

    Curr Eye Res. 2005 May;30(5):395-403.PMID: 16020270 [PubMed - indexed for MEDLINE]Related articles

    17.

    Retinal reattachment facilitated by short-term perfluorocarbon liquid tamponade in a case of fevr and rhegmatogenous retinal detachment.

    Shaikh S, Trese MT.

    Retina. 2002 Oct;22(5):674-6. No abstract available. PMID: 12441744 [PubMed - indexed for MEDLINE]Related articles

    18.

    Repair of a complex retinal detachment with proliferative vitreoretinopathy in an eye with extreme scleral thinning.

    Theodossiadis PG, D'Amico DJ, Weissgold DJ.

    Arch Ophthalmol. 1998 Jun;116(6):812-4. No abstract available. PMID: 9639457 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proliferative vitreoretinopathy: pathobiology and therapeutic targets.

    Leiderman YI, Miller JW.

    Semin Ophthalmol. 2009 Mar-Apr;24(2):62-9. Review.PMID: 19373688 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term results after scleral buckling surgery in uncomplicated juvenile retinal detachment without proliferative vitreoretinopathy.

    Häring G, Wiechens B.

    Retina. 1998;18(6):501-5.PMID: 9869456 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity